Few prior GWAS and targeted genetic analyses further considered APOE*4 status, uncovering promising genes such as Klotho and Fibronectin1 that may counter APOE*418–21, but novel, larger APOE*4 stratified AD GWAS are urgently needed. The gene discussed is APOE; the disease is Alzheimer disease.